Publication not explained

This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.

If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.

Featured Image

Read the Original

This page is a summary of: Aspirin, NOACs, Warfarin: which is the best choice to tackle cognitive decline in elderly patients? Insights from the GIRAF and ASCEND-Dementia trials presented at the AHA 2021, European Heart Journal - Cardiovascular Pharmacotherapy, November 2021, Oxford University Press (OUP),
DOI: 10.1093/ehjcvp/pvab081.
You can read the full text:

Read

Contributors

The following have contributed to this page